2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | 21.906 | 30.723 | 40.261 | 45.089 | 47.223 | 41.945 | 59.364 | 67.623 |
Total Income - EUR | - | - | 21.912 | 30.724 | 40.264 | 45.089 | 47.223 | 41.969 | 59.364 | 67.623 |
Total Expenses - EUR | - | - | 12.443 | 15.702 | 17.930 | 20.781 | 24.618 | 26.523 | 27.831 | 27.613 |
Gross Profit/Loss - EUR | - | - | 9.469 | 15.022 | 22.334 | 24.308 | 22.605 | 15.447 | 31.533 | 40.010 |
Net Profit/Loss - EUR | - | - | 9.250 | 14.715 | 21.931 | 23.857 | 22.133 | 15.027 | 31.005 | 39.348 |
Employees | - | - | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dudaş Med Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Assets | - | - | 10.976 | 16.731 | 23.971 | 34.399 | 52.008 | 45.984 | 58.754 | 70.493 |
Inventories | - | - | 129 | 127 | 125 | 312 | 505 | 494 | 496 | 494 |
Receivables | - | - | 1.330 | 19 | 3.535 | 3.981 | 6.804 | 914 | 5.299 | 11.422 |
Cash | - | - | 9.517 | 16.586 | 20.311 | 30.106 | 44.698 | 44.576 | 52.960 | 58.577 |
Shareholders Funds | - | - | 9.294 | 14.428 | 22.341 | 30.277 | 46.409 | 39.181 | 57.532 | 65.192 |
Social Capital | - | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | 1.682 | 2.304 | 1.630 | 4.122 | 5.599 | 6.803 | 1.222 | 5.302 |
Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8621 - 8621" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Dudaş Med Srl